Mechanistic insights into the effects of quercetin and/or GLP-1 analogue liraglutide on high-fat diet/streptozotocin-induced type 2 diabetes in rats

Biomedicine and Pharmacotherapy

Volumn 92, Issue , 2017, Pages 331-339

  Gaballah, Hanaa H ^a   Zakaria, Soha S ^a   Mwafy, Shorouk E ^a   Tahoon, Nahid M ^a   Ebeid, Abla M ^b  

^a TANTA UNIVERSITY   (Egypt)

^b International Coastal Road   (Egypt)

Author keywords

Apoptosis; Diabetes mellitus; Liraglutide; Protein disulfide isomerase; Quercetin; Spliced XBP1

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CCAAT ENHANCER BINDING PROTEIN; GLUCOSE; GLUTATHIONE; INSULIN; LIRAGLUTIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MALONALDEHYDE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN DISULFIDE ISOMERASE; QUERCETIN; STREPTOZOCIN; X BOX BINDING PROTEIN 1; ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1;

ALBINO RAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DRUG DESIGN; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS TISSUE; PRIORITY JOURNAL; QUANTITATIVE STUDY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UNFOLDED PROTEIN RESPONSE; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; METABOLISM; TREATMENT OUTCOME;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DRUG THERAPY, COMBINATION; GLUCAGON-LIKE PEPTIDE 1; HYPOGLYCEMIC AGENTS; LIRAGLUTIDE; MALE; QUERCETIN; RATS; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 85019902349     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.05.086     Document Type: Article

References (61)

1. Asif, M., The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J. Edu. Health Promot., 3(1), 2014, 1.
2. Cerf, M.E., Beta cell dysfunction and insulin resistance. Front. Endocrinol., 4, 2013, 37.
3. Eizirik, D.L., Miani, M., Cardozo, A.K., Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56:2 (2013), 234–241.
4. Bravo, R., et al. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int. Rev. Cell Mol. Biol., 301, 2013, 215.
5. Keane, K.N., et al. Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxid. Med. Cell. Longevity, 2015, 2015.
6. Gardner, B.M., et al. Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harbor Perspect. Biol., 5(3), 2013, a013169.
7. Fu, X.L., Gao, D.S., Endoplasmic reticulum proteins quality control and the unfolded protein response: the regulative mechanism of organisms against stress injuries. Biofactors 40:6 (2014), 569–585.
8. Sano, R., Reed, J.C., ER stress-induced cell death mechanisms. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1833:12 (2013), 3460–3470.
9. Walter, P., Ron, D., The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:6059 (2011), 1081–1086.
10. Gardner, B.M., Walter, P., Unfolded proteins are Ire1-activating ligands that directly induce the unfolded protein response. Science 333:6051 (2011), 1891–1894.
11. Piperi, C., Adamopoulos, C., Papavassiliou, A.G., XBP1: a pivotal transcriptional regulator of glucose and lipid metabolism. Trends Endocrinol. Metabol. 27:3 (2016), 119–122.
12. Grek, C., Townsend, D., Protein disulfide isomerase superfamily in disease and the regulation of apoptosis. Endoplas. Reti. Stress Dis. 1:1 (2014), 4–17.
13. Gorman, A.M., et al. Stress management at the ER: regulators of ER stress-induced apoptosis. Pharmacol. Ther. 134:3 (2012), 306–316.
14. Tabas, I., Ron, D., Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13:3 (2011), 184–190.
15. Biden, T.J., et al. Lipotoxic endoplasmic reticulum stress, β cell failure, and type 2 diabetes mellitus. Trends Endocrinol. Metabol. 25:8 (2014), 389–398.
16. Holst, J.J., et al. Roles of the gut in glucose homeostasis. Diabetes Care 39:6 (2016), 884–892.
17. Parks, M., Rosebraugh, C., Weighing risks and benefits of liraglutide—the FDA's review of a new antidiabetic therapy. New Engl. J. Med. 362:9 (2010), 774–777.
18. Ekor, M., The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol., 4, 2014, 177.
19. Kumar, S., Pandey, A.K., Chemistry and biological activities of flavonoids: an overview. Sci. World J., 2013, 2013.
20. D'Andrea, G., Quercetin: a flavonol with multifaceted therapeutic applications?. Fitoterapia 106 (2015), 256–271.
21. Srinivasan, K., et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52:4 (2005), 313–320.
22. Hendarto, H., et al. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD (P) H oxidases. Metabolism 61:10 (2012), 1422–1434.
23. de David, C., et al. Role of quercetin in preventing thioacetamide-induced liver injury in rats. Toxicol. Pathol. 39:6 (2011), 949–957.
24. Sturis, J., et al. GLP-1 derivative liraglutide in rats with β-cell deficiencies: influence of metabolic state on β-cell mass dynamics. Br. J. Pharmacol. 140:1 (2003), 123–132.
25. Matthews, D., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:7 (1985), 412–419.
26. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1–2 (1976), 248–254.
27. Holmgren, A., Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J. Biol. Chem. 254:19 (1979), 9627–9632.
28. Hirota, M., et al. Quantitative measurement of spliced XBP1 mRNA as an indicator of endoplasmic reticulum stress. J. Toxicol. Sci. 31:2 (2006), 149–156.
29. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:2 (1979), 351–358.
30. Beutler, E., Duron, O., Kelly, B.M., Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61 (1963), 882–888.
31. Witko-Sarsat, V., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49:5 (1996), 1304–1313.
32. Laybutt, D., et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50:4 (2007), 752–763.
33. Lipson, K.L., et al. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab. 4:3 (2006), 245–254.
34. Chan, J.Y., et al. The balance between adaptive and apoptotic unfolded protein responses regulates β-cell death under ER stress conditions through XBP1, CHOP and JNK. Mol. Cell. Endocrinol. 413 (2015), 189–201.
35. Liu, J., et al. Glucagon-like peptide-1 analog liraglutide protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway. J. Diabetes Res., 2013, 2013.
36. Zheng, J., et al. Therapeutic effects of quercetin on early inflammation in hypertriglyceridemia-related acute pancreatitis and its mechanism. Pancreatology 16:2 (2016), 200–210.
37. Yao, S., et al. Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway. Exp. Biol. Med. 237:7 (2012), 822–831.
38. Tharaheswari, M., et al. Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats. Mol. Cell. Biochem. 396:1–2 (2014), 161–174.
39. Chowdhury, S., et al. Deciphering the role of ferulic acid against streptozotocin-induced cellular stress in the cardiac tissue of diabetic rats. Food Chem. Toxicol. 97 (2016), 187–198.
40. Yao, F., et al. Fatty acid-binding protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy. Mol. Cell. Endocrinol. 411 (2015), 232–242.
41. Bhatta, M., et al. Enhanced endoplasmic reticulum stress in bone marrow angiogenic progenitor cells in a mouse model of long-term experimental type 2 diabetes. Diabetologia 58:9 (2015), 2181–2190.
42. Ji, Y., et al. Liraglutide alleviates diabetic cardiomyopathy by blocking CHOP-triggered apoptosis via the inhibition of the IRE-α pathway. Mol. Med. Rep. 9:4 (2014), 1254–1258.
43. Shiraki, A., et al. The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells. Atherosclerosis 221:2 (2012), 375–382.
44. Guo, X.D., et al. Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation. Mol. Nutrit. Food Res. 57:6 (2013), 1037–1045.
45. Shao, S., et al. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway. J. Cell. Biochem. 115:6 (2014), 1166–1175.
46. Zhu, H., et al. The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3 K/AKT and MAPK pathways. Sci. Rep., 6, 2016.
47. Lee, J., et al. The immunostimulating activity of quercetin 3-O-xyloside in murine macrophages via activation of the ASK1/MAPK/NF-κB signaling pathway. Int. Immunopharmacol. 31 (2016), 88–97.
48. Koliaki, C., Roden, M., Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus. Annu. Rev. Nutr. 36 (2016), 337–367.
49. Govindaraj, J., Pillai, S.S., Rosmarinic acid modulates the antioxidant status and protects pancreatic tissues from glucolipotoxicity mediated oxidative stress in high-fat diet: streptozotocin-induced diabetic rats. Mol. Cell. Biochem. 404:1–2 (2015), 143–159.
50. Shimoda, M., et al. The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetologia 54:5 (2011), 1098–1108.
51. Coskun, O., et al. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol. Res. 51:2 (2005), 117–123.
52. Kanter, M., Aktas, C., Erboga, M., Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis. Food Chem. Toxicol. 50:3 (2012), 719–725.
53. Laurindo, F.R., Pescatore, L.A., de Castro Fernandes, D., Protein disulfide isomerase in redox cell signaling and homeostasis. Free Radic. Biol. Med. 52:9 (2012), 1954–1969.
54. Toldo, S.et al., Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase. Mol. Med., 17(9), 2011, 1012.
55. Nardai, G., et al. Diabetic changes in the redox status of the microsomal protein folding machinery. Biochem. Biophys. Res. Commun. 334:3 (2005), 787–795.
56. Barati, M.T., et al. Differential expression of endoplasmic reticulum stress-response proteins in different renal tubule subtypes of OVE26 diabetic mice. Cell Stress Chaperones 21:1 (2016), 155–166.
57. Noh, H.-J., et al. Quercetin suppresses MIP-1α?Induced adipose inflammation by downregulating its receptors CCR1/CCR5 and inhibiting inflammatory signaling. J. Med. Food 17:5 (2014), 550–557.
58. Huber, J., et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J. Clin. Endocrinol. Metabol. 93:8 (2008), 3215–3221.
59. Kadowaki, H., Nishitoh, H., Signaling pathways from the endoplasmic reticulum and their roles in disease. Genes 4:3 (2013), 306–333.
60. Tate, M.et al., Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages. Basic Res. Cardiol., 111(1), 2016, 1.
61. Zhou, S.J., et al. Liraglutide ameliorates renal injury in streptozotocin-induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor-κB pathway. Mol. Med. Rep. 10:5 (2014), 2587–2594.